Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)
Condition: Chronic Obstructive Pulmonary Disease Intervention: Drug: BGF (budesonide/glycopyrrolate/formoterol fumarate) Sponsor: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2023 Category: Research Source Type: clinical trials